Safe and effective? Effective is out the window within months, safety was never there. The myocarditis concerns are surely the tip of the toxiberg.
According to a peer-reviewed study published in Nature Communications by France researchers, the Moderna and Pfizer vaccines increase myocarditis risk in young adults by 44 times.
For BNT162b2 (Pfizer-BioNTech) and mRNA-1273 (Moderna), the risk of myocarditis after mRNA vaccination was 8 times and 30 times higher than that of the unvaccinated control groups, respectively.
For people between the ages of 18 and 24, there was 44 times higher risk of myocarditis following the Moderna vaccine.
Regarding the Pfizer shot, the risk was 13 times greater in comparison to the same age group.
In comparison, the probability of getting the same condition increased nine times after contracting the Chinese Communist Party virus.
Myocarditis is a potentially fatal condition that refers to the inflammation of the heart muscle. This heart disease has a variety of known causes. The most recent scientific findings indicate that viruses are the primary cause; nevertheless, during the pandemic, COVID mRNA vaccines have established themselves as a leading suspect for myocarditis.
The new study’s objective was to assess the relationship between vaccination and various sex and age groups.
Here’s what the STUDY states:
The largest associations are observed for myocarditis following mRNA-1273 vaccination in persons aged 18 to 24 years [Moderna 44x increase, Pfizer 13x increase]. Estimates of excess cases attributable to vaccination also reveal a substantial burden of both myocarditis and pericarditis across other age groups and in both males and females.
The risk of myocarditis was substantially increased within the first week post vaccination in both males and females (Fig. 1 and Table S2). Odds-ratios associated with the second dose of the mRNA-1273 vaccine were consistently the highest, with values up to 44 (95% CI, 22–88) and 41 (95% CI, 12–140), respectively in males and females aged 18 to 24 years but remaining high in older age groups.
We perform matched case-control studies and find increased risks of myocarditis and pericarditis during the first week following vaccination, and particularly after the second dose, with adjusted odds ratios of myocarditis of 8.1 (95% confidence interval [CI], 6.7 to 9.9) for the BNT162b2 [Pfizer] and 30 (95% CI, 21 to 43) for the mRNA-1273 [Moderna] vaccine.
The association was stronger for the mRNA-1273 vaccine with odds-ratios of 3.0 (95% CI, 1.4–6.2) for the first dose and 30 (95% CI, 21–43) for the second. The risk of pericarditis was increased in the seven days following the second dose of both vaccines, with odds ratios of 2.9 (95% CI, 2.3–3.8) for the BNT162b2 vaccine and 5.5 (95% CI, 3.3–9.0) for the mRNA-1273 vaccine.
“Both SARS-CoV2 infection and COVID mRNA vaccines have been associated with myocarditis. Knowing the spike protein’s affinity to ACE2 receptors in the heart and spike protein’s injury to cardiomyocytes (cells of the heart), the association of myocarditis with SARS-CoV2 virus or spike protein-based mRNA vaccination was not entirely unexpected,” said Dr. Sanjay Verma, a cardiologist.
Additionally, Verma believes that the CDC’s data “erroneously suggests” that the risk of myocarditis following SARS-CoV2 infection is higher than the risk after the COVID-19 mRNA vaccine.
Nevertheless, the CDC and the public health ‘experts’ refuse to divert from the course.
To download the new *peer-reviewed* French study, it can be found here.